Axsome Therapeutics (AXSM) Cash & Equivalents (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.52% |
| Dec 31, 2025 | -0.73% |
| Sep 30, 2025 | 7.35% |
| Jun 30, 2025 | 0.70% |
| Mar 31, 2025 | -4.58% |
| Dec 31, 2024 | -3.65% |
| Sep 30, 2024 | 3.69% |
| Jun 30, 2024 | -4.76% |
| Mar 31, 2024 | -14.18% |
| Dec 31, 2023 | -7.30% |
| Sep 30, 2023 | -4.69% |
| Jun 30, 2023 | 77.33% |
| Mar 31, 2023 | 22.73% |
| Dec 31, 2022 | -11.73% |
| Sep 30, 2022 | 210.00% |
| Jun 30, 2022 | -13.35% |
| Mar 31, 2022 | -2.05% |
| Dec 31, 2021 | -24.54% |
| Sep 30, 2021 | -18.85% |
| Jun 30, 2021 | -14.24% |
| Mar 31, 2021 | -10.45% |
| Dec 31, 2020 | -9.13% |
| Sep 30, 2020 | 6.12% |
| Jun 30, 2020 | -3.36% |
| Mar 31, 2020 | -10.30% |
| Dec 31, 2019 | 404.03% |
| Sep 30, 2019 | -18.81% |
| Jun 30, 2019 | 26.11% |
| Mar 31, 2019 | 205.14% |
| Dec 31, 2018 | -8.23% |
| Sep 30, 2018 | -25.21% |
| Jun 30, 2018 | -23.58% |
| Mar 31, 2018 | -21.72% |
| Dec 31, 2017 | 7.41% |
| Sep 30, 2017 | -16.64% |
| Jun 30, 2017 | -15.60% |
| Mar 31, 2017 | 22.94% |
| Dec 31, 2016 | 8.06% |
| Sep 30, 2016 | -12.55% |
| Jun 30, 2016 | -12.08% |
| Mar 31, 2016 | -8.24% |
| Dec 31, 2015 | 939.55% |
| Sep 30, 2015 | -27.96% |
| Jun 30, 2015 | 279.45% |